Lehman Department of Pathology and Laboratory Medicine Brown Cancer Center Department of Biochemistry and Molecular Genetics University of Louisville 505 South Hancock Street Louisville, KY 40202 USA [email protected] Submitted: 03 April 2022 Accepted: 12 August 2022 Copyedited by: Jeffrey Nirschl Published: 26 August 2022 Keywords: Malignant melanotic nerve sheath tumor, MMNST, Psammomatous melanotic schwannoma, Nerve sheath tumor, Pigmented epithelioid melanocytoma, PRKAR1A, KMT2C, GNAQ Abstract Malignant melanotic nerve sheath tumor (MMNST) is a rare and potentially aggressive lesion defined in the 2021 WHO Classification of Tumors of the Central Nervous System
Prenatal iodine supplementation and early childhood neurodevelopment: the PoppiE trial study protocol for a multicentre randomised controlled trial
Foglietta F, Serpe L, Canaparo R
They can occur anywhere on the body, including in the mouth
Clinical practice has shown that in a substantial number of patients seen in a tertiary care setting, injection frequency cannot be reduced after the initial loading regimen
